Creative Medical Technology Holdings (OTCMKTS:CELZ) Launches MyeloCelz™: What’s The Buzz?
Commercial stage biotechnology company specialising in regenerative stem cell technology, Creative Medical Technology Holdings (OTCMKTS:CELZ) on 20th July announced launch of its second Regenerative Immunology product, MyeloCelz. The firm’s ImmCelz product harnesses T cells and B cells for inducing activation of own stem cells and healing. On the other hand, MyeloCelzuses innate immune system, especially cells of monocyte/macrophage lineage. Thomas Ichim, Ph.D, Chief Scientific Officer, and Co-Founder said that…